Adicet Bio, Inc. (ACET) ADI-001 Phase 1 Clinical Update Call Transcript
Source: SeekingAlpha
2025-10-07 12:48:57 ET
Adicet Bio, Inc. (ACET) ADI-001 Phase 1 Clinical Update Call
Company Participants
Chen Schor - CEO, President & Director
Julie Maltzman - Chief Medical Officer
Blake Aftab - Senior VP & Chief Scientific Officer ...
Read the full article on Seeking Alpha
For further details see:
Adicet Bio, Inc. (ACET) ADI-001 Phase 1 Clinical Update Call Transcript
Adicet Bio Inc.
NASDAQ: ACET
ACET Trading
3.33% G/L:
$7.75 Last:
114,296 Volume:
$7.60 Open:
ACET Latest News
January 30, 2026 07:00:00 am
Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
January 07, 2026 07:00:00 am
Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones
ACET Stock Data
$70,641,246
7,595,730
46.88%
30
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
